论文部分内容阅读
目的总结加诺(Gal-le-Donau)对肝胆疾病的治疗作用。方法通过多家医院临床研究;15年胆石门诊总结分析;胆石术后再发结石治疗;难治胆道术后感染病人治疗进行总结。结果北京5家三甲医院对102例临床研究,对急慢性胆囊炎及其慢性肝病治疗,总有效率82%,其中显效47%,有效35%;对再发结石42例,采用加诺合用熊去氧胆酸(UDCA)治疗,8例痊愈,30例有效。结论加诺有促进真性胆汁分泌、抗炎性水肿、降低胆固醇、增加胆汁中抗生素浓度作用;加诺可用于胆石症溶石、胆道感染治疗和预防胆石形成并有预防胆道感染的效果。用在肝胆道及消化系统症状的改善和功能恢复。
Objective To summarize the therapeutic effect of Gal-le-Donau on hepatobiliary diseases. Methods A number of hospital clinical studies; 15 years of gallstones clinic summary analysis; recurrence of gallstone stones after treatment; refractory biliary tract infection in patients with treatment to be summarized. Results A total of 102 clinical trials were conducted in 5 top 3 hospitals in Beijing. The total effective rate was 82%, of which 47% and 35% were effective in the treatment of acute and chronic cholecystitis and chronic liver diseases. Forty-two patients with recurrent stones were treated with Gano- Deoxycholic acid (UDCA) treatment, 8 patients recovered, 30 cases effective. Conclusion Garonne can promote true bile secretion, anti-inflammatory edema, lower cholesterol, and increase the concentration of antibiotics in bile. Garonnos can be used for the treatment of cholelithiasis and biliary tract infection, prevention of gallstone formation and prevention of biliary tract infection. Used in the improvement of liver and biliary tract and digestive system symptoms and functional recovery.